- Home
- HOPE vs CLDX Comparison
HOPE vs CLDX Comparison
Compare HOPE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOPE
- CLDX
- Stock Information
- Founded
- HOPE 1986
- CLDX N/A
- Country
- HOPE United States
- CLDX United States
- Employees
- HOPE N/A
- CLDX N/A
- Industry
- HOPE Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HOPE Finance
- CLDX Health Care
- Exchange
- HOPE Nasdaq
- CLDX Nasdaq
- Market Cap
- HOPE 1.4B
- CLDX 1.6B
- IPO Year
- HOPE 1996
- CLDX 2008
- Fundamental
- Price
- HOPE $11.12
- CLDX $22.87
- Analyst Decision
- HOPE Buy
- CLDX Strong Buy
- Analyst Count
- HOPE 2
- CLDX 9
- Target Price
- HOPE $13.25
- CLDX $46.13
- AVG Volume (30 Days)
- HOPE 700.8K
- CLDX 1.6M
- Earning Date
- HOPE 10-27-2025
- CLDX 11-05-2025
- Dividend Yield
- HOPE 5.06%
- CLDX N/A
- EPS Growth
- HOPE N/A
- CLDX N/A
- EPS
- HOPE 0.34
- CLDX N/A
- Revenue
- HOPE $412,692,000.00
- CLDX $5,790,000.00
- Revenue This Year
- HOPE $17.88
- CLDX N/A
- Revenue Next Year
- HOPE $11.76
- CLDX N/A
- P/E Ratio
- HOPE $32.53
- CLDX N/A
- Revenue Growth
- HOPE N/A
- CLDX N/A
- 52 Week Low
- HOPE $8.83
- CLDX $14.40
- 52 Week High
- HOPE $14.54
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- HOPE 60.07
- CLDX 51.69
- Support Level
- HOPE $10.89
- CLDX $21.77
- Resistance Level
- HOPE $11.29
- CLDX $23.69
- Average True Range (ATR)
- HOPE 0.22
- CLDX 1.36
- MACD
- HOPE 0.06
- CLDX -0.00
- Stochastic Oscillator
- HOPE 75.86
- CLDX 48.36
About HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.